BCG VACCINE is a Percutaneous Injection, Powder, Lyophilized, For Solution in the Vaccine category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Bacillus Calmette-guerin Substrain Tice Live Antigen.
| Product ID | 0052-0603_0417ae29-951b-48bb-a877-44223882d15f |
| NDC | 0052-0603 |
| Product Type | Vaccine |
| Proprietary Name | BCG VACCINE |
| Generic Name | Bacillus Calmette-guerin Substrain Tice Live Antigen |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | PERCUTANEOUS |
| Marketing Start Date | 1989-06-21 |
| Marketing Category | BLA / BLA |
| Application Number | BLA103050 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [CS],BCG Vaccine [CS],Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC],Increased Macrophage Proliferation [PE],Increased Immunologically Active Molecule Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |